EDGAR Filing Documents for 0001193125-23-139563

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-23-139563

Filing Date

2023-05-09

Accepted

2023-05-09 17:27:22

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d364942ds3.htm	S-3	443499
2	EX-4.3	d364942dex43.htm	EX-4.3	342820
3	EX-4.4	d364942dex44.htm	EX-4.4	353958
4	EX-4.5	d364942dex45.htm	EX-4.5	33120
5	EX-4.6	d364942dex46.htm	EX-4.6	33832
6	EX-5.1	d364942dex51.htm	EX-5.1	32367
7	EX-23.1	d364942dex231.htm	EX-23.1	2611
8	EX-FILING FEES	d364942dexfilingfees.htm	EX-FILING FEES	78203
9	GRAPHIC	g364942d1.jpg	GRAPHIC	15773
10	GRAPHIC	g364942d2.jpg	GRAPHIC	3562
11	GRAPHIC	g364942g00g00.jpg	GRAPHIC	40352
	Complete submission text file	0001193125-23-139563.txt		1400402

Mailing Address 40 GUEST STREET BOSTON MA 02135

Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680

Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)